From Arterial Hypertension to Stroke–Heart Syndrome: Contemporary Approaches to Cardio-Cerebrovascular Care Based on the European Society of Cardiology Congress

Bondarenko D.V.

Main
Publications
From Arterial Hypertension to Stroke–Heart Syndrome: Contemporary Approaches to Cardio-Cerebrovascular Care Based on the European Society of Cardiology Congress

November 12, 2026

134

Bondarenko D.V.

УДК: УДК 616.12-008.331.1:616.831-005.1

DOI: DOI:10.32471/umj.1680-3051.282482

Keywords :

acute stroke,

anticoagulant therapy,

arterial hypertension,

atrial fibrillation,

secondary stroke prevention,

stroke–heart syndrome

Resume

This article summarizes contemporary approaches to cardio-cerebrovascular care presented at ESC Congress 2026. It discusses blood pressure management during the acute phase of stroke, as well as the pathophysiological mechanisms and clinical manifestations of stroke–heart syndrome. The prognostic significance of cardiac complications, current strategies for initiating and resuming anticoagulant therapy, and approaches to secondary prevention of ischemic stroke in patients with atrial fibrillation are reviewed. Particular attention is given to integrated models of cardio-cerebrovascular care and opportunities to reduce residual cardiovascular risk.

References

1. Scheitz J.F., Nolte C.H., Doehner W. et al. (2018) Stroke–heart syndrome: clinical presentation and underlying mechanisms. Lancet Neurol., 17(12): 1109–1120. DOI: 10.1016/S1474-4422(18)30336-3.
2. Doehner W., Böhm M., Boriani G. et al. (2023) Interaction of heart failure and stroke: a clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association and the ESC Working Group on Thrombosis. Eur. J. Heart Fail., 25(12): 2107–2129. DOI: 10.1002/ejhf.3071.
3. Doehner W. (2026) Stroke-heart-syndrome: does it exist and why should cardiologists be worried? ESC Congress 2026, Munich, Germany.
4. Scheitz J.F., Mochmann H.C., Erdur H. et al. (2014) Prognostic relevance of cardiac troponin T levels and their dynamic changes measured with a high-sensitivity assay in acute ischaemic stroke: analyses from the TRELAS cohort. Int. J. Cardiol., 177: 886–893. DOI: 10.1016/j.ijcard.2014.10.036.
5. Wira C.R. III, Rivers E., Martinez-Capolino C. et al. (2011) Cardiac complications in acute ischemic stroke. West. J. Emerg. Med., 12(4): 414–420. DOI: 10.5811/westjem.2011.2.1765.
6. Katan M. (2026) Optimising re-initiation of oral anticoagulation after stroke or intracranial bleeding: a catalyst for optimising the timing of direct oral anticoagulants. ESC Congress 2026, Munich, Germany.
7. Fischer U., Koga M., Strbian D. et al. (2023) Early versus later anticoagulation for stroke with atrial fibrillation. N. Engl. J. Med. DOI: 10.1056/NEJMoa2303048.
8. Dehbi H.-M., Fischer U., Åsberg S. et al. (2025) Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials. Lancet. DOI: 10.1016/S0140-6736(25)00439-8.
9. Veltkamp R., Korompoki E., Harvey K.H. et al. (2025) Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF). Lancet, 405(10482): 927–936. DOI: 10.1016/S0140-6736(25)00333-2.
10. Caso V. (2026) Clinical complexity in cardio-cerebrovascular care: definition, prognosis, and optimal management. ESC Congress 2026, Munich, Germany.
11. Polymeris A.A., Meinel T.R., Oehler H. et al. (2022) Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. J. Neurol. Neurosurg. Psychiatry, 93(6): 588–598. DOI: 10.1136/jnnp-2021-328391.
12. Okazaki S., Tanaka K., Yazawa Y. et al. (2025) Optimal antithrombotics for ischemic stroke and concurrent atrial fibrillation and atherosclerosis: a randomized clinical trial. JAMA Neurol. DOI: 10.1001/jamaneurol.2025.3662.
13. Whitlock R.P., Belley-Cote E.P., Paparella D. et al. (2021) Left atrial appendage occlusion during cardiac surgery to prevent stroke. N. Engl. J. Med., 384(22): 2081–2091. DOI: 10.1056/NEJMoa2101897.
14. Jensen M., Suling A., Metzner A. et al. (2023) Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial. Lancet Neurol., 22(1): 45–54. DOI: 10.1016/S1474-4422(22)00436-7.
15. Li M. (2026) Tackling the residual cardiovascular risk of stroke or cardiovascular events through integrated care: do we need a miracle? ESC Congress 2026, Munich, Germany.
16. Sagris D., Lip G.Y.H., Korompoki E. et al. (2024) Adherence to an integrated care pathway for stroke is associated with lower risk of major cardiovascular events: a report from the Athens Stroke Registry. Eur. J. Intern. Med., 122: 61–67. DOI: 10.1016/j.ejim.2023.12.010.
17. Tsang C.T.W., Choi S.E., Bucci T. et al. (2025) Integrated care using the ABCstroke pathway improves cardiovascular outcomes and survival in patients with first-ever ischaemic stroke. Glob. Heart, 20(1): 46. DOI: 10.5334/gh.1430.
18. Chu M., Zhang S., Gong J. et al. (2025) Telemedicine-based integrated management of atrial fibrillation in village clinics: a cluster randomized trial. Nat. Med., 31(4): 1276–1285. DOI: 10.1038/s41591-025-03511-2.